Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
Recruiting
Observational Study
Prostate Cancer (Diagnosis)
Clinically Significant Prostate Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 90
- Sex
- Male
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Guangxi Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter observational study. A deep learning model integrated with multimodal imaging and digital pathology spatial registration is built based on preoperative multiparametric magnetic resonance imaging, transrectal ultrasound and postoperative digital pathological whole slide images. The study is designed to achieve accurate prediction of clinically significant prostate cancer and n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Subjects who are scheduled to undergo or have undergone prostate biopsy or radical prostatectomy.
2. Subjects who have completed standard-of-care preoperative multiparametric MRI (mpMRI) and transrectal ultrasound (TRUS) examinations.
3. Subjects with complete pathological di…
Contacts